E2F6 Gene

E2F6 (E2F Transcription Factor 6)

Gene Information

<div class="infobox infobox-gene">
[@e2f_family]
| Property | Value | [@e2f6_repressor]
|---------|-------| [@polycomb_e2f6]
| Gene Symbol | E2F6 |
| Full Name | E2F Transcription Factor 6 |
| Chromosomal Location | 2p25.1 |
| NCBI Gene ID | [1876](https://www.ncbi.nlm.nih.gov/gene/1876) |
| OMIM ID | 602944 |
| Ensembl ID | ENSG00000169081 |
| UniProt ID | [O75141](https://www.uniprot.org/uniprot/O75141) |
| Protein Length | 294 amino acids |
| Molecular Weight | 31.7 kDa |
| Protein Family | E2F transcription factor family |
</div>

Overview

E2F6 (E2F Transcription Factor 6) is a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, gene expression, and cellular differentiation. Unlike other E2F family members that primarily function as transcriptional activators or repressors of cell cycle genes, E2F6 possesses unique structural features that enable it to act as a specialized transcriptional repressor involved in chromatin remodeling and gene silencing.

The E2F6 protein is encoded by the E2F6 gene located on chromosome 2p25.1. It contains a DNA-binding domain characteristic of E2F transcription factors but lacks the canonical transcriptional activation domain found in other E2F proteins. This structural difference underpins E2F6's specialized function as a transcriptional repressor and its involvement in chromatin-based gene silencing mechanisms.

E2F6 (E2F Transcription Factor 6)

Gene Information

<div class="infobox infobox-gene">
[@e2f_family]
| Property | Value | [@e2f6_repressor]
|---------|-------| [@polycomb_e2f6]
| Gene Symbol | E2F6 |
| Full Name | E2F Transcription Factor 6 |
| Chromosomal Location | 2p25.1 |
| NCBI Gene ID | [1876](https://www.ncbi.nlm.nih.gov/gene/1876) |
| OMIM ID | 602944 |
| Ensembl ID | ENSG00000169081 |
| UniProt ID | [O75141](https://www.uniprot.org/uniprot/O75141) |
| Protein Length | 294 amino acids |
| Molecular Weight | 31.7 kDa |
| Protein Family | E2F transcription factor family |
</div>

Overview

E2F6 (E2F Transcription Factor 6) is a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, gene expression, and cellular differentiation. Unlike other E2F family members that primarily function as transcriptional activators or repressors of cell cycle genes, E2F6 possesses unique structural features that enable it to act as a specialized transcriptional repressor involved in chromatin remodeling and gene silencing.

The E2F6 protein is encoded by the E2F6 gene located on chromosome 2p25.1. It contains a DNA-binding domain characteristic of E2F transcription factors but lacks the canonical transcriptional activation domain found in other E2F proteins. This structural difference underpins E2F6's specialized function as a transcriptional repressor and its involvement in chromatin-based gene silencing mechanisms.

E2F6's role in cell cycle regulation and gene silencing has significant implications for [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). Dysregulation of cell cycle control in neurons is a recognized feature of neurodegenerative diseases, and E2F6 may contribute to both protective and pathogenic processes.

Molecular Structure and Function

Protein Structure

The E2F6 protein consists of several functional domains that mediate its unique functions. The N-terminal region contains a DNA-binding domain consisting of a helix-loop-helix (HLH) motif that recognizes the E2F consensus DNA sequence TTTSSCGC (where S = G or C). This domain allows E2F6 to bind to promoter regions of target genes[@e2f_family].

Unlike other E2F family members, E2F6 lacks a canonical transactivation domain and instead contains motifs that mediate interaction with chromatin-modifying complexes. The C-terminal region is involved in dimerization with other E2F proteins, allowing E2F6 to form heterodimers that can regulate gene expression.

Transcriptional Repression Mechanisms

E2F6 employs multiple mechanisms to repress gene expression[@e2f6_repressor]:

These mechanisms allow E2F6 to regulate genes independently of cell cycle control, making it particularly important in post-mitotic cells like neurons.

Tissue Distribution

E2F6 is widely expressed in human tissues, with highest expression in the brain, testes, and embryonic tissues. In the brain, E2F6 is expressed in both neuronal and glial populations, with particular abundance in regions of active neurogenesis and synaptic remodeling.

Role in Neuronal Development

Neurogenesis

During development, E2F6 plays critical roles in regulating neurogenesis[@development_neurons]:

• Progenitor Cell Proliferation: E2F6 helps maintain appropriate proliferation rates of neural progenitor cells by repressizing cell cycle genes.
• Cell Fate Determination: E2F6-mediated silencing of specific genes helps determine neuronal versus glial cell fate.
• Cortical Development: E2F6 regulates genes important for cortical layering and neuronal migration.

Synapse Formation

E2F6 influences synaptic development through its effects on gene expression:

• Synaptic Protein Expression: E2F6 regulates genes encoding synaptic structural proteins and neurotransmitter receptors.
• Dendritic Development: Through transcriptional regulation, E2F6 affects dendritic arborization patterns.
• Prewiring: E2F6 helps establish appropriate patterns of synaptic connectivity during development.

Adult Neurogenesis

In the adult brain, E2F6 continues to regulate neurogenesis in the subventricular zone and hippocampal subgranular zone[@adult_neurogenesis]. It helps maintain the balance between neural stem cell proliferation and differentiation.

Synaptic Plasticity and Cognitive Function

In mature neurons, E2F6 contributes to synaptic plasticity[@synaptic_plasticity]:

• Activity-Dependent Gene Repression: Following neuronal activation, E2F6 helps re-establish transcriptional programs that promote appropriate synaptic strengthening or weakening.
• Memory Consolidation: E2F6-mediated gene repression is required for proper memory consolidation in rodent models.
• Circadian Regulation: E2F6 participates in circadian transcriptional regulation in neurons, which is increasingly recognized as important for cognitive function.

Role in Neurodegeneration

Cell Cycle Dysregulation

A key mechanism by which E2F6 may influence neurodegeneration is through cell cycle control[@cell_cycle_neurons]:

Alzheimer's Disease

E2F6 is relevant to AD pathogenesis through multiple mechanisms[@neuronal_death]:

• Cell Cycle Re-entry: In AD, neurons inappropriately re-enter the cell cycle. E2F6 normally helps maintain post-mitotic status; its dysfunction may contribute to this pathological re-entry.
• Amyloid Processing: E2F6 regulates genes involved in amyloid precursor protein (APP) processing and Aβ metabolism.
• Tau Pathology: Through its effects on cell cycle genes, E2F6 may influence tau phosphorylation and aggregation[@tau_pathology].
• Synaptic Dysfunction: E2F6's role in synaptic plasticity may be compromised in AD, contributing to synaptic loss.
• Neuroinflammation: E2F6-regulated genes include inflammatory mediators; its dysfunction may exacerbate neuroinflammation.

Parkinson's Disease

Emerging evidence links E2F6 to PD[@parkinson_cell_cycle]:

• Dopaminergic Neuron Survival: E2F6 helps maintain the post-mitotic status of dopaminergic neurons; its dysregulation may contribute to their vulnerability in PD.
• α-Synuclein Expression: E2F6 may regulate genes involved in α-synuclein processing and aggregation.
• Mitochondrial Function: E2F6 regulates genes involved in mitochondrial dynamics, which is central to PD pathogenesis.
• Neuroinflammation: Through its effects on inflammatory gene expression, E2F6 may modulate the neuroinflammatory environment in PD.

Amyotrophic Lateral Sclerosis

E2F6 may also play a role in ALS:

• Motor Neuron Vulnerability: E2F6 dysfunction may contribute to the pathological cell cycle re-entry observed in ALS motor neurons.
• RNA Metabolism: E2F6 regulates genes involved in RNA processing, which is disrupted in ALS.
• Excitotoxicity: Through gene regulation, E2F6 may influence glutamate receptor expression and excitotoxicity.

Epigenetic Dysregulation

E2F6's role in chromatin remodeling has implications for neurodegeneration[@epigenetic_regulation]:

• Global Epigenetic Changes: AD and PD are associated with widespread epigenetic alterations. E2F6 dysfunction may contribute to these changes.
• Gene-Specific Silencing: Incorrect gene silencing by E2F6 may lead to inappropriate repression of neuroprotective genes.
• Polycomb Interaction: E2F6's interaction with Polycomb proteins may be altered in neurodegeneration, affecting silencing of developmental genes.

DNA Damage Response

E2F6 participates in the DNA damage response[@dna_damage]:

• p53 Regulation: E2F6 can repress p53 expression, affecting the balance between DNA repair and apoptosis[@p53_interaction].
• Cell Cycle Arrest: E2F6 helps establish cell cycle arrest following DNA damage.
• Genomic Stability: Through its effects on cell cycle control, E2F6 helps maintain genomic stability in neurons.

Cellular Senescence

E2F6 dysfunction may contribute to cellular senescence in neurodegeneration[@senescence]:

• Senescence-Associated Secretory Phenotype: E2F6 dysregulation may promote SASP in neurons and glia.
• Cell Cycle Exit: Prolonged E2F6 dysfunction may lead to irreversible cell cycle exit and senescence.
• Age-Related Changes: E2F6 function may decline with aging, contributing to age-related neurodegeneration.

Therapeutic Implications

Target Strategies

E2F6 represents a potential therapeutic target[@therapeutic_target]:

Biomarker Potential

E2F6 expression and variants may serve as biomarkers:

• Genetic Variants: E2F6 variants may identify individuals at risk for neurodegeneration.
• Expression Levels: E2F6 expression in peripheral blood or CSF may correlate with disease status.
• Epigenetic Markers: E2F6 promoter methylation may be a biomarker for neurodegeneration.

Challenges

Several challenges must be addressed:

Research Directions

Key questions remaining about E2F6 include:

Cross-Links

• [Cell Cycle Dysregulation in Neurodegeneration](/mechanisms/cell-cycle-dysregulation)
• [Transcription Factors in Neurodegeneration](/mechanisms/transcription-factor-dysregulation)
• [Alzheimer's Disease Overview](/diseases/alzheimers-disease)
• [Parkinson's Disease Overview](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Epigenetics in Neurodegeneration](/mechanisms/epigenetic-regulation-neurodegeneration)

External Links

• [Ensembl: ENSG00000169081](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000169081)
• [NCBI Gene: E2F6](https://www.ncbi.nlm.nih.gov/gene/?term=E2F6)
• [GeneCards: E2F6](https://www.genecards.org/cgi-bin/carddisp.pl?gene=E2F6)
• [OMIM: E2F6](https://omim.org/search?search=E2F6)
• [Allen Brain Atlas: E2F6](https://human.brain-map.org/microarray/search/show?search_term=E2F6)

References